| Debra L Hildebrand, MED | |
|
415 Ray C Hunt Dr, Uva Ent Clinic At Fontaine, Charlottesville, VA 22903 | |
| (434) 924-2050 | |
| (434) 982-0700 |
| Full Name | Debra L Hildebrand |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 43 Years |
| Location | 415 Ray C Hunt Dr, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023142197 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 2201000256 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine that will potentially help combat hepatitis C. Michael Houghton, who led the team that discovered the hepatitis C virus in 1989, announced his findings at the Canada Excellence Research Chairs Summit in Vancouver this afternoon. Currently, there are no vaccines against the disease available.
Anthem Blue Cross and Blue Shield in Wisconsin (Anthem) announced today the expansion of its industry-leading transparency initiative to northcentral Wisconsin. Now, all members in Florence, Forest, Langlade, Lincoln, Marathon, Oneida, Portage, Vilas and Wood counties will be able to access Anthem Care Comparison, an online tool that provides information about the costs of 35 specific medical procedures performed at local area hospitals, outpatient surgery centers and free-standing radiology facilities.
A short-term fast appears to counteract increases in blood sugar caused by common cancer drugs and protect healthy cells in mice from becoming too vulnerable to chemotherapy, according to new research from the University of Southern California.
IQ Therapeutics has completed the dosing of antibody IQNLF in a Phase I clinical trial. A total of 36 healthy volunteers participated in the randomized, placebo controlled, double blind, single dose-escalating study, intended to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of IQNLF.
Kaiser Health News staff writer Andrew Villegas writes: "People recently laid off are waiting - once again - to hear if they will be eligible to get subsidies to stay on their employer's health insurance.
› Verified 4 days ago
| Provider Name | University Of Virginia Physicians Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine that will potentially help combat hepatitis C. Michael Houghton, who led the team that discovered the hepatitis C virus in 1989, announced his findings at the Canada Excellence Research Chairs Summit in Vancouver this afternoon. Currently, there are no vaccines against the disease available.
Anthem Blue Cross and Blue Shield in Wisconsin (Anthem) announced today the expansion of its industry-leading transparency initiative to northcentral Wisconsin. Now, all members in Florence, Forest, Langlade, Lincoln, Marathon, Oneida, Portage, Vilas and Wood counties will be able to access Anthem Care Comparison, an online tool that provides information about the costs of 35 specific medical procedures performed at local area hospitals, outpatient surgery centers and free-standing radiology facilities.
A short-term fast appears to counteract increases in blood sugar caused by common cancer drugs and protect healthy cells in mice from becoming too vulnerable to chemotherapy, according to new research from the University of Southern California.
IQ Therapeutics has completed the dosing of antibody IQNLF in a Phase I clinical trial. A total of 36 healthy volunteers participated in the randomized, placebo controlled, double blind, single dose-escalating study, intended to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of IQNLF.
Kaiser Health News staff writer Andrew Villegas writes: "People recently laid off are waiting - once again - to hear if they will be eligible to get subsidies to stay on their employer's health insurance.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Debra L Hildebrand, MED 500 Ray C Hunt Dr, Charlottesville, VA 22903-2981 Ph: (434) 980-6140 | Debra L Hildebrand, MED 415 Ray C Hunt Dr, Uva Ent Clinic At Fontaine, Charlottesville, VA 22903 Ph: (434) 924-2050 |
News Archive
A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine that will potentially help combat hepatitis C. Michael Houghton, who led the team that discovered the hepatitis C virus in 1989, announced his findings at the Canada Excellence Research Chairs Summit in Vancouver this afternoon. Currently, there are no vaccines against the disease available.
Anthem Blue Cross and Blue Shield in Wisconsin (Anthem) announced today the expansion of its industry-leading transparency initiative to northcentral Wisconsin. Now, all members in Florence, Forest, Langlade, Lincoln, Marathon, Oneida, Portage, Vilas and Wood counties will be able to access Anthem Care Comparison, an online tool that provides information about the costs of 35 specific medical procedures performed at local area hospitals, outpatient surgery centers and free-standing radiology facilities.
A short-term fast appears to counteract increases in blood sugar caused by common cancer drugs and protect healthy cells in mice from becoming too vulnerable to chemotherapy, according to new research from the University of Southern California.
IQ Therapeutics has completed the dosing of antibody IQNLF in a Phase I clinical trial. A total of 36 healthy volunteers participated in the randomized, placebo controlled, double blind, single dose-escalating study, intended to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of IQNLF.
Kaiser Health News staff writer Andrew Villegas writes: "People recently laid off are waiting - once again - to hear if they will be eligible to get subsidies to stay on their employer's health insurance.
› Verified 4 days ago
Nicola L. Ratcliffe, M.ED. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 415 Ray C Hunt Dr, Uva Ent Clinic At Fontaine, Charlottesville, VA 22903 Phone: 434-924-2050 Fax: 434-982-0700 | |
Bailey R. Aksland, AUD, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 415 Ray C Hunt Dr Ste 2200, Charlottesville, VA 22903 Phone: 434-924-2050 Fax: 434-243-5207 | |
Ms. Linda Jean Swinson, CCC-AUDIOLOGY Audiologist Medicare: Not Enrolled in Medicare Practice Location: 218 W Market Street, Suite 7, Charlottesville, VA 22902 Phone: 434-293-7368 Fax: 434-293-5752 | |
Mr. Bruce Robert Wagner, CCC AUDIOLOGY Audiologist Medicare: Not Enrolled in Medicare Practice Location: 218 West Market St, Suite 7, Charlottesville, VA 22902 Phone: 434-293-7368 Fax: 434-293-5752 | |
Dr. Manuela C. Aguilar, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 417 Emmet Street, South, Charlottesville, VA 22904 Phone: 434-924-7034 Fax: 434-924-4621 | |
Cynthia A Clark, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 415 Ray C Hunt Dr Ste 1200, Charlottesville, VA 22903 Phone: 434-924-2050 Fax: 434-982-0700 |